According to the Cleveland Clinic, a quarter of cancer deaths can be attributed to one source: cachexia. Cachexia is a syndrome that accompanies underlying chronic illness and causes unwanted muscle and fat loss, reducing quality of life and sometimes even limiting treatment options.
A new study led by Thales Papagiannakopoulos, Ph.D., an incoming Salk professor, published in Science, points to a potential new target for preventing cachexia.
The researchers found that a common genetic subset of lung cancer is more prone to cachexia and that tumors from this subtype talk to the brain through sensory neurons in the lung. Silencing these sensory nerves to disrupt the tumor-to-brain connection reduced cachexia, as did blocking the production of the lipid signaling molecule prostaglandin E2 (PGE2) through dietary changes.
Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn’t moved past 115 years. But is that about to change?
The Limit host Daniel T. Allen spent months talking to medical researchers, biohackers, and centenarians. He also went through a battery of tests worth over $12,000 at a longevity clinic to find out how long he might live.
In this episode, Business Insider looked into what could radically extend human lifespan, including FDA-approved drugs, cellular reprogramming, and Bryan Johnson’s $2 million \.
The theory of immune regulation involves a homeostatic balance between T-helper 1 (Th1) and T-helper 2 (Th2) responses. The Th1 and Th2 theories were introduced in 1986 as a result of studies in mice, whereby T-helper cell subsets were found to direct different immune response pathways. Subsequently, this hypothesis was extended to human immunity, with Th1 cells mediating cellular immunity to fight intracellular pathogens, while Th2 cells mediated humoral immunity to fight extracellular pathogens. Several disease conditions were later found to tilt the balance between Th1 and Th2 immune response pathways, including HIV infection, but the exact mechanism for the shift from Th1 to Th2 cells was poorly understood. This review provides new insights into the molecular biology of HIV, wherein the HIV life cycle is discussed in detail.
The researchers also built in a warning signal. When the cell received a confusing instruction—the biological equivalent of two commands arriving at once—it produced a separate alert instead of continuing as if nothing had happened.
To show how the system might one day be used in medicine, the team programmed cells to secrete IL-15, an immune protein that can help activate cancer-fighting immune cells.
The experiments relied on engineered circuits delivered into cells under controlled lab conditions. The authors note several challenges ahead, including avoiding unwanted RNA interactions, limiting leaky genetic switches, and finding reliable ways to insert larger circuits into cell genomes.
Nanoparticles are widely used in medicine to deliver drugs, genes or imaging agents to specific parts of the body. Once a nanoparticle reaches a cell, however, many things can happen—it can reach its target, be degraded, interact with proteins that help transport it, or interact with proteins that hinder its transport.
A longstanding problem in designing nanomedicines has been understanding what happens to nanoparticles at the cellular level, but scientists have faced many challenges. For example, optical microscopy imaging techniques provide only a generalized view of nanomedicine localization.
On the other hand, proteomics approaches require cell lysis, which disrupts the natural distribution of proteins around the nanoparticle, making it difficult to understand how nanoparticles are transported within the cell. Another method—proximity labeling—enables in situ investigation of intracellular protein-protein interactions, but it relies on genetically engineered enzyme fusion, which limits its applicability across diverse systems.
A new type of hip replacement implant reduces the risk of joint dislocation after surgery by 70%, according to a new study involving 1,600 patients across 44 hospitals in Sweden and the UK, published in The Lancet. The new implant consists of a small ball encased in a much larger plastic ball, which provides better stability.
Each year, more than 14 million patients worldwide suffer a femoral neck fracture. Total hip replacement (THR), in which both the ball and socket of the hip are replaced, is recommended for older, active individuals with a displaced fracture of the femoral neck. While the vast majority regain good mobility and quality of life, up to 8% of these patients experience a dislocation of their hip, a very painful condition in which the artificial joint slips out of place.
In 2023, scientists at the Paris Brain Institute investigated one of the most fascinating and unsettling transitions in neuroscience: what happens to the cortex when the brain is deprived of oxygen.
In a rat model of systemic anoxia, researchers found that the dying brain does not simply “shut off” all at once. Instead, cortical activity follows a structured sequence: brief high-frequency activity, slowing oscillations, electrical silence, and then a massive wave of anoxic depolarization — often called the “wave of death.”
This wave appeared to begin deep in the neocortex, especially around layer 5 pyramidal neurons, before spreading upward toward the cortical surface and downward toward the white matter. These neurons are large, metabolically demanding projection cells, which may make them especially vulnerable when oxygen and ATP collapse.
But the most important part of the study is that this wave did not always represent an absolute point of no return. When oxygenation was restored within a critical window, researchers observed a “wave of resuscitation,” followed by partial recovery of synaptic activity.
That does not mean death has been “reversed” in a simple or sensational sense. But it does suggest something scientifically powerful: the boundary between life and death in the brain may be more dynamic, layered, and measurable than we often imagine.
This is where the implications become fascinating.
If the “wave of death” is an organized biophysical event, future neurocritical care may one day be able to detect the brain’s approach toward irreversible injury in real time. Instead of relying only on broad markers like heartbeat, oxygen saturation, or flat EEG, clinicians may eventually use more detailed brain-state monitoring to identify whether the cortex is entering a reversible, borderline, or irreversible phase.